24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825

Medical Disorders
Resources
Basic InformationLookupsLatest News
Two Lives Saved in Rare 'Paired' Liver DonationYour Life Span May Be Foretold in Your Heart BeatsHealth Tip: Stopping NosebleedsKids Can Get UTIs, TooIs a New Remedy for Body Odor on the Horizon?Why More Patients Are Surviving an AneurysmCommon Diabetes Drug May Also Shield Kidneys, HeartIsraeli Team Announces First 3D-Printed Heart Using Human Cells'Added Sugars' Label on Foods Could Save Many LivesCPAP Brings Longer Life for Obese People With Sleep Apnea: StudyYoung Athletes Need to Be Sidelined After Bout of MonoPre-Cut Melons at Kroger, Walmart, Other Stores May Carry SalmonellaCDC Says Ground Beef Is Source of E. coli Outbreak, Cases Rise to 109AHA News: Is Yoga Heart-Healthy? It's No Stretch to See Benefits, Science SuggestsFDA Orders Label Warning on Alcohol Use With 'Female Viagra'Could Treating Gut Bacteria Help Ease Autism Symptoms?Hospital Privacy Curtains Could Be Breeding Ground for GermsItchy Skin Common Alongside Kidney DiseaseMany Misdiagnosed With MSVehicle Exhaust Drives Millions of New Asthma Cases AnnuallyNFL Retirees Help Scientists Develop Early Test for Brain Condition CTEMigraine Pain Linked to Raised Suicide RiskMore Time Spent in Sports, Faster Healing From ConcussionHealth Tip: Thermometer OptionsStill No Source as E. Coli Outbreak Grows to 96 Cases Across 5 States: CDCClimate Change Could Worsen Sneezin' SeasonEvenity Approved for Osteoporotic WomenNYC Declares Public Health Emergency Over Brooklyn Measles OutbreakInsurers' Denials of Opioid Coverage Spurs CDC to Clarify GuidelinesImmune-Targeted Treatment Might Help Prevent Peanut Allergy CrisesCluster of Dangerous Antibiotic-Resistant E. Coli Infection Spotted in NYCHealth Tip: Managing Chronic MigrainesFor One Man, Too Much Vitamin D Was DisastrousCDC Investigates Mystery E. Coli Outbreak Affecting 5 StatesBlacks Live Longer, Not Necessarily Better, With ALSIs It Heartburn or Something Else?Lungs, Hearts Infected With Hepatitis C Still OK for TransplantUnhealthy Diets May Be World's Biggest KillerSevere 'Mono' Infection May Raise Risk for Chronic Fatigue SyndromeUnder-the-Tongue Allergy Pills Replacing Shots for ManyFish Slime Could Hold Key to Beating 'Superbug' InfectionsPet Hedgehogs Still Spreading Salmonella, CDC WarnsCimzia Approved for Inflammatory ArthritisSpring Is the Sneezing SeasonU.S. Flu Season Ebbing, but Cases Still Widespread: CDCLab-Grown Blood Vessels Could Be Big Medical AdvanceClimate Change Will Aid Spread of Disease-Bearing MosquitoesSurgeons Perform First HIV-Positive Kidney Transplant From Living DonorAncestry Matters When Seeking Matched Bone Marrow DonorsBad Info May Be Scaring Patients Away From Heart-Healthy Statins
Questions and AnswersLinks
Related Topics

Diabetes

Blood Thinning Drug May Be Safer Option Against Recurrent Stroke

HealthDay News
by -- Robert Preidt
Updated: Feb 7th 2019

new article illustration

THURSDAY, Feb. 7, 2019 (HealthDay News) -- Taking the blood thinner Pletal (cilostazol) with either aspirin or clopidogrel (best known as Plavix) lowers stroke patients' risk of a subsequent stroke better than taking aspirin or clopidogrel alone, a new study finds.

The Japanese study was funded by Pletal's maker, Otsuka Pharmaceutical, and tracked outcomes for people with the most common form of stroke, ischemic stroke. These are strokes caused by blocked blood flow to the brain.

Low-dose aspirin and clopidogrel have been shown to reduce the risk of a second stroke early in ischemic stroke patients' recovery, said study lead author Dr. Kazunori Toyoda. But he added that the benefits of those two blood thinners are brief and must be balanced with a risk of major bleeding after long-term use.

Toyoda is deputy director general of the National Cerebral and Cardiovascular Center in Suita, Osaka, Japan.

Pletal has been shown to prevent further strokes in stroke patients without increasing serious bleeding as compared to aspirin, Toyoda said. So his team decided to assess whether long-term use of the drug with other blood thinners might be safe and effective.

The study included more than 1,800 high-risk patients in Japan who had suffered an ischemic stroke up to six months earlier. Each was randomly assigned to receive aspirin or clopidogrel alone, or a combination of Pletal with aspirin or clopidogrel, at one of 292 sites across Japan over about three years.

As reported Feb. 6 at the American Stroke Association's annual meeting in Honolulu, Hawaii, the study found the risk of another ischemic stroke was halved for patients who took Pletal plus aspirin or clopidogrel, versus those who took aspirin or clopidogrel alone.

Specially, 29 of 913 patients (3.2 percent) who took Pletal plus another blood thinner went on to have another stroke, compared to 64 of 926 patients (6.9 percent) who took aspirin or clopidogrel alone, the investigators found.

Adding Pletal to the mix didn't seem to affect patient safety, however. According to the researchers, patients in the study experienced a similar risk of major bleeding -- about 1 percent -- regardless of which regimen they were on.

One cardiologist who wasn't connected to the new study said the findings were encouraging.

"The decrease in stroke recurrence with unchanged bleeding risk is remarkable," said Dr. Satjit Bhusri, who practices at Lenox Hill Hospital in New York City.

"Stroke treatment has long lagged heart attack treatment," Bhusri said. "It is reassuring to see that similar treatments correlate and if this continues, we can further study more advanced medicines already used in the heart for the brain as well."

Because these findings were presented at a medical meeting, they should be considered preliminary until published in a peer-reviewed journal.

More information

The National Stroke Association has more on ischemic stroke.